CA 125 in Benign Gynecological Conditions
- 1 October 1998
- journal article
- research article
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 13 (4) , 231-237
- https://doi.org/10.1177/172460089801300411
Abstract
The tumor marker CA 125 was initially thought to be specific for ovarian malignancies. Subsequently it was found to be raised in a variety of benign conditions, including pregnancy, pelvic inflammatory disease, tuberculosis and cirrhosis of the liver. With respect to gynecological tumors, CA 125 may be elevated in benign ovarian cysts, tubo-ovarian abscess, endometriosis, hyperstimulation syndrome, ectopic pregnancy and fibroids. These results demonstrate that CA 125 is a marker of non-specific peritoneal conditions.Keywords
This publication has 41 references indexed in Scilit:
- Clinical validation of the new ELSA‐CA 125 II assay: Report of a european multicentre evaluationInternational Journal of Cancer, 1995
- What Is a Normal CA125 Level?Gynecologic Oncology, 1994
- What do we know about the origin of CA 125?European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
- Plasma and peritoneal fluid levels of CA 125 in women with endometriosisAmerican Journal of Obstetrics and Gynecology, 1988
- Serum Concentration of Protein CA-125 in Women with Pelvic Inflammatory DiseaseSexually Transmitted Diseases, 1988
- Serum CA 125 in epithelial ovarian cancer. A longitudinal studyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Elevated serum concentrations of CA-125 in patients with advanced endometriosisFertility and Sterility, 1986
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981